Page last updated: 2024-08-18

pyrroles and Pneumonia, Bacterial

pyrroles has been researched along with Pneumonia, Bacterial in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corriden, R; Griffin, JH; Gupta, N; Liu, R; Nizet, V; Pogliano, J; Pogliano, K; Shin, S; Sinha, R1
Beynat, C; Coudert, B; Diaz, P; Favier, L; Ghiringhelli, F; Ladoire, S1
Belder, R; Braunwald, E; Breen, J; Cannon, CP; McCabe, CH1

Other Studies

3 other study(ies) available for pyrroles and Pneumonia, Bacterial

ArticleYear
SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity.
    The Journal of antimicrobial chemotherapy, 2018, 06-01, Volume: 73, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Lung; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia, Bacterial; Pyrroles; Quinazolines; Reactive Oxygen Species; Receptor, PAR-1

2018
Spontaneous pyopneumothorax in patients treated with mTOR inhibitors for subpleural pulmonary metastases.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Calcitonin; Carcinoma, Renal Cell; Combined Modality Therapy; Disease Susceptibility; Everolimus; Fatal Outcome; Female; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Proteins; Nephrectomy; Niacinamide; Phenylurea Compounds; Pneumonia, Bacterial; Pneumothorax; Protein Precursors; Pyridines; Pyrroles; Rupture, Spontaneous; Sirolimus; Sorafenib; Sunitinib; TOR Serine-Threonine Kinases

2010
Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial.
    The American journal of cardiology, 2002, Apr-01, Volume: 89, Issue:7

    Topics: Angina, Unstable; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol, LDL; Double-Blind Method; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multicenter Studies as Topic; Myocardial Infarction; Pneumonia, Bacterial; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design

2002